Table 1.

Comparison of patient baseline characteristics in the IGRT and non-IGRT groups

T stage	IGRT	Non-IGRT	P value
1	78(30%)	9(35%)
2	137(52%)	13(50%)
3a	40(15%)	3(12%)
3b	6(2%)	0(0%)
4	0(0%)	1(4%)
Not available	4(1%)	0
Total	265	26	0.8987
Gleason
≤ 6	61(23%)	9(35%)
7	147(55%)	11(42%)
8	31(12%)	2(8%)
9	21(8%)	3(12%)
10	1(0.4%)	1(4%)
Not available	4(1%)	0
Total	265	26	0.5782
PSA (ng/ml)
< 4	13(5%)	0(0%)
4-10	126(48%)	14(54%)
10.1-20	85(32%)	8(31%)
> 20	37(14%)	4(15%)
Not available	4(1%)	0
Total	265	26	0.661
Prior TURP	56 (21%)	6 (23%)	0.8043
Neoadjuvant LHRH agonist	131 (50%)	11 (42%)	0.5407
Diabetes	61 (23%)	4 (15%)	0.4656
Hypertension	145 (55%)	13 (50%)	0.6827